PCN67 - Economic Assessment of Routine Oncotype DX Testing of Estrogen Receptor Positive (ER+) Early Breast Cancer (EBC) Patients with Grade 2 Tumours in Czech Republic

K Hejduk,K Petrakova,L Petruzelka,Z Bielcikova,I Kolarova,J Finek,M Burger,P Ovesná,I Feigler,J Silar,Z Zbozinkova

doi:10.1016/j.jval.2016.09.2140

PCN67 - Economic Assessment of Routine Oncotype DX Testing of Estrogen Receptor Positive (ER+) Early Breast Cancer (EBC) Patients with Grade 2 Tumours in Czech Republic

K Hejduk, K Petrakova + Show 9 more

Open Access

https://doi.org/10.1016/j.jval.2016.09.2140

Copy DOI

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research	Publication Date: Oct 31, 2016
Citations: 1	License type: publisher-specific-oa

Affiliation: Masaryk University, General University Hospital in Prague

#Positive Early Breast Cancer Patients #Estrogen Receptor Positive Early Breast + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

PCN67 - Economic Assessment of Routine Oncotype DX Testing of Estrogen Receptor Positive (ER+) Early Breast Cancer (EBC) Patients with Grade 2 Tumours in Czech Republic

Full Text